1. Home
  2. ABUS vs BYRN Comparison

ABUS vs BYRN Comparison

Compare ABUS & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • BYRN
  • Stock Information
  • Founded
  • ABUS N/A
  • BYRN 2005
  • Country
  • ABUS United States
  • BYRN United States
  • Employees
  • ABUS N/A
  • BYRN N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • BYRN Industrial Machinery/Components
  • Sector
  • ABUS Health Care
  • BYRN Miscellaneous
  • Exchange
  • ABUS Nasdaq
  • BYRN Nasdaq
  • Market Cap
  • ABUS 629.1M
  • BYRN 660.7M
  • IPO Year
  • ABUS N/A
  • BYRN N/A
  • Fundamental
  • Price
  • ABUS $3.42
  • BYRN $28.51
  • Analyst Decision
  • ABUS Strong Buy
  • BYRN Strong Buy
  • Analyst Count
  • ABUS 4
  • BYRN 3
  • Target Price
  • ABUS $5.50
  • BYRN $17.75
  • AVG Volume (30 Days)
  • ABUS 646.4K
  • BYRN 666.8K
  • Earning Date
  • ABUS 03-03-2025
  • BYRN 02-07-2025
  • Dividend Yield
  • ABUS N/A
  • BYRN N/A
  • EPS Growth
  • ABUS N/A
  • BYRN N/A
  • EPS
  • ABUS N/A
  • BYRN 0.55
  • Revenue
  • ABUS $6,742,000.00
  • BYRN $85,756,000.00
  • Revenue This Year
  • ABUS N/A
  • BYRN $28.90
  • Revenue Next Year
  • ABUS N/A
  • BYRN $20.96
  • P/E Ratio
  • ABUS N/A
  • BYRN $51.84
  • Revenue Growth
  • ABUS N/A
  • BYRN 101.10
  • 52 Week Low
  • ABUS $2.30
  • BYRN $7.79
  • 52 Week High
  • ABUS $4.72
  • BYRN $34.78
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 54.07
  • BYRN 46.43
  • Support Level
  • ABUS $3.24
  • BYRN $27.26
  • Resistance Level
  • ABUS $3.44
  • BYRN $33.93
  • Average True Range (ATR)
  • ABUS 0.12
  • BYRN 2.75
  • MACD
  • ABUS 0.01
  • BYRN -0.23
  • Stochastic Oscillator
  • ABUS 55.56
  • BYRN 31.85

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

About BYRN Byrna Technologies Inc.

Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.

Share on Social Networks: